Impairment of rigidity sensing caused by mutant TP53 gain of function in osteosarcoma
Abstract Osteosarcoma (OS) is the most common primary malignant pediatric bone tumor and is characterized by high heterogeneity. Studies have revealed a wide range of phenotypic differences among OS cell lines in terms of their in vivo tumorigenicity and in vitro colony-forming abilities. However, t...
Main Authors: | Ming Luo, Mingyang Huang, Ningning Yang, Yufan Zhu, Peng Huang, Zhujun Xu, Wengang Wang, Lin Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-05-01
|
Series: | Bone Research |
Online Access: | https://doi.org/10.1038/s41413-023-00265-w |
Similar Items
-
Regulators of Oncogenic Mutant TP53 Gain of Function
by: Satomi Yamamoto, et al.
Published: (2018-12-01) -
TP53 in Biology and Treatment of Osteosarcoma
by: Kamil Jozef Synoradzki, et al.
Published: (2021-08-01) -
Inhibition of <i>TP53</i> Mutant Oral Cancer by Reactivating p53
by: Yei-Jin Kang, et al.
Published: (2022-06-01) -
Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
by: Stephen L. Abrams, et al.
Published: (2022-02-01) -
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
by: Jin-Ah Kim, et al.
Published: (2023-09-01)